The measurement of plasma half-life involves administering the nanoparticles and then collecting blood samples at various time points. The concentration of the nanoparticles in the plasma is quantified using techniques like High-Performance Liquid Chromatography (HPLC) or mass spectrometry. The data is then plotted to determine the half-life through pharmacokinetic modeling.
